Ophthalmic Business News

Joseph C. Papa, chair of the board of directors at Bausch + Lomb, has stepped down, according to a press release.

The FDA accepted a new drug application for intravitreal pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration and granted priority review designation, according to a press release.

AbbVie and iSTAR Medical have entered into a strategic alliance to develop and commercialize the MINIject minimally invasive glaucoma surgical device for patients with glaucoma, according to a press release.

Carl Zeiss Meditec and Precise Bio have partnered to develop and commercialize fabricated corneal tissue for endothelial keratoplasty and natural lenticule transplants to treat keratoconus and vision correction.

In the sixth part of a 12-part series, Peter J. Polack, MD, FACS, discusses the importance of having a follow-up process and how it can affect return on investment.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Randy Mansfield of BioTissue provides an update on the company’s upcoming projects inside and outside of ophthalmology.

DORC International has received FDA 510(k) clearance for Eva Nexus, the first surgical system cleared for subretinal injection, according to a press release.

There are no activities that are completely risk free. Whether a person decides to eat, drive or sky dive, there is some level of risk involved.

In the fifth part of a 12-part series, Peter J. Polack, MD, FACS, explains two key benefits to using detailed marketing maps for campaigns.

Bausch + Lomb and Novaliq have submitted a new drug application for NOV03 to the FDA for the treatment of signs and symptoms dry eye disease associated with meibomian gland dysfunction, according to a press release.